Method for treating transplant patients using mycalamide compoun

Details Method for treating transplant patients using mycalamide compoun Method for treating transplant patients using mycalamide compoun

1992-12-14

1994-03-29

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514456, A61K 3135, A01N 4332

Patent

active

052985237

ABSTRACT:
Mycalamide compounds are derived from marine sponges of the genus Mycale or prepared by synthetic methods. These compounds, and pharmaceutical compositions containing them as active ingredients, are useful as immunomodulatory agents.

REFERENCES:
patent: 4548814 (1985-10-01), Rinehart, Jr.
patent: 4729996 (1988-03-01), Wright et al.
patent: 4737510 (1988-04-01), Rinehart, Jr.
patent: 4808590 (1989-02-01), Higa et al.
patent: 4868204 (1989-09-01), Blunt
Faulkner, D. J., (1984), "Marine Natural Products: Metabolites of Marine Invertebrates", Natural Product Reports, 1:551-598.
Uemura, Daisuke, Kanji Takabashi, and Toshihiro Yamamoto, (1985), "Norhalichondrin A: An Antitumor Polyether Macrolike from a Marine Sponge", J. Am. Chem. Soc., 107(16):4796-4798.
Faulkner, D. J., (1987), "Marine Natural Products", Natural Products Reports, 4(5):539-576.
Faulkner, D. J., (1986), "Marine Natural Products", Natural Products Reports, 3:1-33.

Affiliated with

Also associated with

Rating

Method for treating transplant patients using mycalamide compoun does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating transplant patients using mycalamide compoun, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating transplant patients using mycalamide compoun will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-792160